Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data
PLOS Computational Biology · 2023
DOI: 10.1371/journal.pcbi.1011020 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2023. Verfasst von Krystian Zieliński und 9 weiteren Autor:innen. Beteiligte Einrichtung: INVICTA Research and Development Center, Sopot, Poland. Hauptthemen laut MEDLINE: Ovarian Follicle, Anti-Mullerian Hormone. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.
Abstract (Originalsprache)
Controlled ovarian stimulation is tailored to the patient based on clinical parameters but estimating the number of retrieved metaphase II (MII) oocytes is a challenge. Here, we have developed a model that takes advantage of the patient’s genetic and clinical characteristics simultaneously for predicting the stimulation outcome. Sequence variants in reproduction-related genes identified by next-generation sequencing were matched to groups of various MII oocyte counts using ranking, correspondence analysis, and self-organizing map methods. The gradient boosting machine technique was used to train models on a clinical dataset of 8,574 or a clinical-genetic dataset of 516 ovarian stimulations. The clinical-genetic model predicted the number of MII oocytes better than that based on clinical data. Anti-Müllerian hormone level and antral follicle count were the two most important predictors while a genetic feature consisting of sequence variants in the GDF9 , LHCGR , FSHB , ESR1 , and ESR2 genes was the third. The combined contribution of genetic features important for the prediction was over one-third of that revealed for anti-Müllerian hormone. Predictions of our clinical-genetic model accurately matched individuals’ actual outcomes preventing over- or underestimation. The genetic data upgrades the personalized prediction of ovarian stimulation outcomes, thus improving the in vitro fertilization procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- INVICTA Research and Development Center, Sopot, Poland.
- Department of Biomedical Engineering, Faculty of Electronics, Telecommunications and Informatics, Gdańsk University of Technology, Gdańsk, Poland.
- Institute of Computer Science, Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw, Warsaw, Poland.
- MIM Solutions, Research and Development Center, Warsaw, Poland.
- Department of Medical Biology and Genetics, Faculty of Biology, University of Gdańsk, Gdańsk, Poland.
ORCID-Profile: Joanna Jakóbkiewicz-Banecka
Förderung
- European Regional Development Fund
Zitieren
APA
Zieliński, K., Pukszta, S., Mickiewicz, M., Kotlarz, M., Wygocki, P., Zieleń, M., Drzewiecka, D., Drzyzga, D., Kloska, A., & Jakóbkiewicz-Banecka, J. (2023). Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1011020
Vancouver
Zieliński K, Pukszta S, Mickiewicz M, Kotlarz M, Wygocki P, Zieleń M, et al. Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data. PLOS Computational Biology. 2023. doi:10.1371/journal.pcbi.1011020
BibTeX
@article{Zieliski2023,
author = {Zieliński, Krystian and Pukszta, Sebastian and Mickiewicz, Małgorzata and Kotlarz, Marta and Wygocki, Piotr and Zieleń, Marcin and Drzewiecka, Dominika and Drzyzga, Damian and Kloska, Anna and Jakóbkiewicz-Banecka, Joanna},
title = {Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data},
journal = {PLOS Computational Biology},
year = {2023},
doi = {10.1371/journal.pcbi.1011020}
}
EUVIMED